Physician profile
Stuart W Honick
NPI 1225013725
$4,111.21
in general payments reported to CMS, 2019-2025
14 companies · $1,544 in 2025
The $1,544 reported for 2025 was more than what 78% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,331 · 2020: $26.65 · 2022: $37.85 · 2023: $80.67 · 2024: $91.34 · 2025: $1,544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,277 · Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,277.29 |
| Food and Beverage | $438.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,914.00 | 2019 | |
| Treace Medical Concepts, INC. | $1,508.26 | 2023-2025 | |
| Liberty Surgical INC. | $367.88 | 2019 | |
| Kerecis Limited | $59.78 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abbvie INC. | $49.68 | 2023 | |
| Globus Medical, INC. | $48.12 | 2023-2024 | Captivate Vl, Ankle Fracture System |
| Stryker Corporation | $47.84 | 2019-2024 | Graftjacket |
| Smith+Nephew, INC. | $38.13 | 2019-2025 | Collagenase Santyl, Regranex |
| Paragon 28, INC. | $15.62 | 2022 | |
| Paratek Pharmaceuticals, INC. | $14.76 | 2020 | |
| Melinta Therapeutics, LLC | $13.02 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.05 | 2022 | |
| Kci USA, INC. | $11.89 | 2020 | |
| Grt US Holding, INC. | $10.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Honick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.